US Hemp Roundtable: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION
Cannabis Law Report
MAY 18, 2022
Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The results renew calls from the hemp and CBD industries urging FDA to take steps to regulate CBD now, and calling on Congress to act if FDA continues to delay. The methods for both phases were the same.
Let's personalize your content